Amendment No. 3, dated April 14, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh

EX-10.1 2 ex10-1.htm


Exhibit 10.1


Amendment No. 3


Separation Agreement


April 14, 2020


Reference is hereby made to that certain Separation Agreement between Abeona Therapeutics, Inc. (the “Company”) and Steven Rouhandeh (the “Executive”), dated January 2, 2020 (the “Separation Agreement”).


WHEREAS, the Company and the Executive desire to amend the Separation Agreement,


NOW THEREFORE, the parties hereby agree as follows:


  1. Section 1 is hereby amended by adding the following sentence to the end of Section 1:


“After the Separation Date you shall be an inactive employee for a period of six (6) months, during which time you shall be available for up to a maximum often (10) hours per month for consultation on transition matters.”


  Abeona Therapeutics, Inc.
  /s/ Mark J. Alvino
  By: Mark J. Alvino
  Title: Chair Comp. Comm
  /s/ Steven H. Rouhandeh
  Steven H. Rouhandeh